Krishna Institute of Medical Sciences Limited has informed the Exchange about Transcript
KIMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
KIMS Hospital reported a record Q3 FY26 with total revenue crossing INR1,003 crores for the first time, up 2.2% YoY and 3.9% QoQ. However, EBITDA declined marginally to INR204 crores with margins compressing sharply to 20.4% (from 25.9% in Q3 FY25), and PAT fell to INR52 crores from INR93 crores YoY, with EPS down 39.9%. The margin pressure was attributed to new hospitals (Bangalore-Mahadevapura, Electronic City, Thane) still in ramp-up phase. Operational metrics were strong: ARPOB grew 20.5% YoY and IP volumes rose 13.2% YoY. Management guided that Thane and Mahadevapura should reach EBITDA break-even by Q1 FY27, and Electronic City by Q3 FY27. Net debt stood at ~INR2,850 crores as of Dec 31, 2025, which the CFO indicated has peaked. Capex for FY27 is guided at INR500-600 crores. The company also announced a new hospital in Chennai via a 26-year land lease, targeting completion in 2 years.
The transcript reveals near-term margin pressure from new hospital ramp-ups dragging profitability, but management's clear break-even timelines and guidance that debt has peaked offer medium-term comfort. Investors should expect EBITDA recovery from FY27 once new units stabilize, while monitoring insurance empanelment progress at new Maharashtra and Karnataka facilities.